Hypofractionated vs. conventional radiation therapy for stage III non-small cell lung cancer treated without chemotherapy.
Conclusions: In the appropriate clinical context, HFRT can be an option for patients with locally advanced NSCLC who are not candidates for chemotherapy or surgical resection. HFRT needs to be further studied in prospective trials to evaluate toxicity and tumor control.
PMID: 31608751 [PubMed - as supplied by publisher]
Source: Acta Oncologica - Category: Cancer & Oncology Authors: Iocolano M, Wild AT, Hannum M, Zhang Z, Simone CB, Gelblum D, Wu AJ, Rimner A, Shepherd AF Tags: Acta Oncol Source Type: research
More News: Academia | Cancer | Cancer & Oncology | Chemotherapy | Databases & Libraries | Lung Cancer | Non-Small Cell Lung Cancer | Radiation Therapy | Toxicology